89. COVID-19 INFECTION IN HEMODIALYSIS PATIENTS:FINDINGS-EXPERIENCE-OUTCOME
I. Griveas
417 Army Share Fund Hospital of Athens, Greece
58th ERA-EDTA Congress, Berlin June 5-8, 2021
90. HEMOPERFUSION IN HEMODIALYSIS PATIENTS WITH COVID-19 INFECTION: IMPACT ON CLINICAL COURSE
I. Griveas
417 Army Share Fund Hospital of Athens, Greece
58th ERA-EDTA Congress, Berlin June 5-8, 2021
91.EFFECTIVESS OF HEMOPERFUSION ON HEMODIALYSIS(HD) PATIENTS WITH COVID-19I NFECTION.
I. Griveas*, E. Pratilas, G. Asimakopoulos
Nephrology Department Army Share Fund Hospital of Athens, Greece (417NIMTS)
39th Vicenza Course on AKI and CRRT, 26-29 October 2021
92. SmartPD™ Automated Peritoneal Dialysis System as a New Sophisticated Choice for Urgent Integration in Replacement Therapy for a Patient with ESRD
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
ASN-Renal Week , San Diego , 4-7 November 2021
100. Citrate (CD): The Green alternative to heparin in hemodialysis (HD)
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece
62nd ERA-EDTA Congress, Vienna June 4-7 , 2025
101. Successful Iptacopan Treatment of a Patient with C3 Glomerulopathy (C3G)
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.ASN-Renal Week , Houston , 5-9 November 2025
93. Dapagliflozin and kidney outcomes in CKD patients with and without Type II Diabetes: Real Life Data Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens, Greece.
59th ERA-EDTA Congress, Paris May 19-22, 2022
94. DAPAGLIFLOZIN AND PROGRESSION OF CKD IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES: PRELIMINARY DATA
Ioannis Griveas
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.World Congress of Nephrology 2023, Bangkok March 30 - April 2, 2023.
95. PROLONGED USE OF INTRADIALYSIS PARENTERAL NUTRITION IN HEMODIALYSIS PATIENTS AFTER HOPSITALIZATION
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.World Congress of Nephrology 2023, Bangkok March 30 - April 2, 2023.
96. THE USE OF PLASMA REMOVAL IN A PATIENT WITH PANCREATITIS DUE TO HYPERTRIGLYCERIDEMIA
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.World Congress of Nephrology 2023, Bangkok March 30 - April 2, 2023.
97. "Experience comparing the use of citric acid solution (CD) with L-ascorbic acid (Vitamin C) to simple citric solution in patients with End-Stage Renal Disease (ESRD) under hemodialysis (HD)."
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.ASN-Renal Week , Philadelphia , 2-5 November 2023
98. THE EXPERIENCE FROM THE USE OF CITRIC ACID BLOOD PURIFICATION SOLUTION (CD) WITH L-ASCORBIC ACID (VITAMIN-C) IN PATIENTS UNDER HD
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
61st ERA-EDTA Congress, Stockholm & Virtual, May 23-26, 2024
99. Impact of Dapagliflozin on Anemia Status of patients with CKD
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
